English Visit Patient Site Helping Patients Breathe Easier, Do More & Enjoy Life Breakthrough Technology for Severe Emphysema The Zephyr Valve delivers durable clinical benefits – without surgery and its associated risks.1-5 Patients experience:1-5 Improved health status Improved lung function Increased exercise capacity Reduced breathlessness or dyspnea Reduced gas trapping Improved quality of life GOLD’s evidence “A” rating affirms that endobronchial valves, like the Zephyr® Valve, are a viable, minimally–invasive treatment option for severe emphysema, a form of COPD.10 How It Works See how the Zephyr Valve treatment is performed as a minimally invasive lung volume reduction procedure to reduce hyperinflation and gas trapping in patients with severe emphysema. The Zephyr Valve is the first endobronchial valve to receive approval from the FDA for patients with either heterogenous and homogeneous emphysema. Learn More Selecting the Right Patient Assess with Certainty. Treat with Confidence. Pulmonx provides a comprehensive solution for identifying eligible patients, using tools to help physicians precisely identify: Patients most likely to benefit from Zephyr Valve treatment Target lobes for treatment, which could include upper and/or lower lobes Learn More Durable Clinical Benefits for Patients1-5 Clinically-proven, safe and effective treatment for patients with severe emphysema Consistent clinical findings across four randomized control trials Learn More FEV1 Change From Baseline1 (p<0.001) Δ=17.96 Zephyr Valve(n=128) 12 Months -10 -5 0 5 10 15 20 25 Percent Change (%) *Intent to Treat 6MWD Change From Baseline1 p=0.002 Zephyr Valve(n=128) 12 Months -40 -30 -20 -10 0 10 20 30 40 Meters (m) SGRQ Change From Baseline1 p=0.004 Zephyr Valve(n=128) 12 Months -20 -15 -10 -5 0 5 10 Points (pts) Patient Benefits & Risks Patients treated with the Zephyr Valve compared to patients on medication alone were able to:1 Return to activities that were previously limited Feel less shortness of breath Walk longer distances Have more energy Feel more confident leaving their home Complications of the Zephyr Endobronchial Valve treatment can include but are not limited to pneumothorax, worsening of COPD symptoms, hemoptysis, pneumonia, dyspnea and, in rare cases, death. JC’s Story Age at Treatment: 77 Zephyrhills, Florida Retired railroad engineer back fishing in the Florida sunshine and spending time with his wife. View More Greg’s Story Age at Treatment: 64 Morrisville, Indiana Unfortunately, my sister, who first told me about the valves, passed away from the disease so it is important for me to share my story to let others know about this treatment option before it’s too late. View More Jeffrey’s Story Age at Treatment: 61 Concord, North Carolina I had immediate relief and felt like I was a 40-year-old again. I’m enjoying things I haven’t been able to enjoy in a while. I would recommend the procedure for anyone who qualifies! View More Gary’s Story Age at Treatment: 72 Monroe, Louisiana These valves certainly changed my life for the better and I just want to help spread the word so others can have hope too. View More View All Need more? US Treatment Centers OUS Treatment Centers Connect With Us ©2020 Pulmonx Corporation or its affiliates. All rights reserved. All trademarks are property of their respective owners. | Site Designed by The Deciding Factor, Inc. P0980EN_A February 2019 Resources About Pulmonx Management Team Company History For Patients For Physicians Contact Us Privacy Policy EU and UK Privacy Policy Terms of Use Sitemap Prescriptive Information Follow Us In order to provide you with an optimal website experience, we use cookies. By clicking "Accept" you agree to the use of cookies. Further information can be found in our privacy policy.Accept